CF Pharmtech, Inc. recently successfully completed series E round financing of US$630 million. This round of financing is led by the United new capital investment, CR-CP Life, Junxin capital, Source Venture Capital, Cornerstone Capital, Xiangcheng District financial control, Langma Feng Investment and other well-known institutions also invested. Yuanhe Holdings, Suzhou Longmen Venture Capital Fund, Gaotejia […]
CF PharmTech Completes $630M Series E Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.